AMBRISENTAN

AMBRISENTAN was reported 124905 times

AMBRISENTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENDOPNOEA 70 0.3182
1 TRANSPLANT EVALUATION 134 0.2638
2 OXYGEN CONSUMPTION 42 0.2593
3 INFUSION SITE PUSTULE 31 0.2422
4 CATHETER SITE PRURITUS 211 0.2403
5 PULMONARY ARTERIAL HYPERTENSION 3364 0.2319
6 CATHETER SITE VESICLES 45 0.2308
7 DEVICE WIRELESS COMMUNICATION ISSUE 59 0.2278
8 INFUSION SITE INFECTION 502 0.2158
9 PULMONARY HYPERTENSIVE CRISIS 57 0.2103
10 CATHETER SITE RASH 91 0.2013
11 OXYGEN CONSUMPTION INCREASED 480 0.2007
12 OXYGEN SUPPLEMENTATION 146 0.1973
13 WALKING DISTANCE TEST ABNORMAL 75 0.1918
14 CATHETER SITE DISCHARGE 209 0.1859
15 DEVICE MAINTENANCE ISSUE 109 0.1854
16 CATHETERISATION CARDIAC 807 0.1818
17 PULMONARY ARTERIAL PRESSURE INCREASED 292 0.1791
18 RIGHT VENTRICULAR FAILURE 1244 0.1773
19 LUNG TRANSPLANT 619 0.1747
20 INFUSION SITE DISCHARGE 306 0.1744
21 VENTILATION PERFUSION MISMATCH 46 0.1637
22 CATHETER MANAGEMENT 145 0.1613
23 CONTINUOUS POSITIVE AIRWAY PRESSURE 37 0.1602
24 INFUSION SITE VESICLES 84 0.1597
25 INFUSION SITE CELLULITIS 83 0.1572
26 CATHETER SITE ERYTHEMA 336 0.1569
27 SCLERODERMA 564 0.1550
28 CATHETER SITE IRRITATION 51 0.1532
29 PULMONARY ARTERIAL PRESSURE ABNORMAL 43 0.1493
30 CATHETERISATION CARDIAC ABNORMAL 38 0.1407
31 SICKLE CELL ANAEMIA 90 0.1395
32 CREST SYNDROME 33 0.1387
33 INFUSION SITE IRRITATION 177 0.1377
34 INFUSION SITE WARMTH 168 0.1370
35 VASCULAR DEVICE OCCLUSION 46 0.1357
36 INFUSION SITE PAIN 1732 0.1343
37 CENTRAL VENOUS CATHETERISATION 403 0.1335
38 PULMONARY VENO-OCCLUSIVE DISEASE 93 0.1329
39 INFUSION SITE OEDEMA 109 0.1304
40 INFUSION SITE HAEMORRHAGE 405 0.1230
41 PULMONARY HYPERTENSION 2556 0.1226
42 CATHETER SITE INFLAMMATION 68 0.1208
43 COR PULMONALE 115 0.1204
44 INFUSION SITE INFLAMMATION 84 0.1190
45 INFUSION SITE INDURATION 174 0.1173
46 CATHETER REMOVAL 41 0.1148
47 INFUSION SITE ERYTHEMA 960 0.1138
48 CATHETER SITE SWELLING 102 0.1090
49 FLUID RETENTION 5493 0.1079
50 BIOPSY LUNG 39 0.1060
51 CATHETER PLACEMENT 196 0.1056
52 CATHETER SITE PAIN 259 0.0997
53 INFUSION SITE ABSCESS 50 0.0992
54 PARACENTESIS 61 0.0992
55 CATHETER SITE EXTRAVASATION 38 0.0952
56 DEVICE ALARM ISSUE 172 0.0947
57 LIFE SUPPORT 53 0.0945
58 DIZZINESS EXERTIONAL 71 0.0934
59 INFUSION SITE SWELLING 574 0.0911
60 VASCULAR DEVICE INFECTION 408 0.0898
61 PAIN IN JAW 2521 0.0889
62 INFUSION SITE DISCOLOURATION 78 0.0886
63 INFUSION SITE RASH 120 0.0874
64 FLUID OVERLOAD 1203 0.0826
65 DEVICE INFUSION ISSUE 203 0.0818
66 CATHETER SITE HAEMORRHAGE 199 0.0795
67 INFUSION SITE NODULE 76 0.0791
68 HYPERVOLAEMIA 391 0.0790
69 INFUSION SITE PRURITUS 249 0.0788
70 CENTRAL VENOUS CATHETER REMOVAL 36 0.0768
71 INFUSION SITE SCAR 34 0.0767
72 DYSPNOEA AT REST 218 0.0752
73 INFUSION SITE DISCOMFORT 75 0.0723
74 INFUSION SITE REACTION 211 0.0706
75 HEART TRANSPLANT 63 0.0696
76 DYSPNOEA EXERTIONAL 2602 0.0690
77 MECHANICAL VENTILATION 129 0.0678
78 CHRONIC RESPIRATORY FAILURE 80 0.0662
79 OEDEMA 3570 0.0658
80 NOCTURNAL DYSPNOEA 83 0.0650
81 NASAL CONGESTION 3820 0.0649
82 MINERAL SUPPLEMENTATION 29 0.0647
83 SICKLE CELL DISEASE 29 0.0628
84 CARBON DIOXIDE INCREASED 84 0.0616
85 DEVICE RELATED INFECTION 916 0.0594
86 OXYGEN SATURATION ABNORMAL 165 0.0581
87 LOWER RESPIRATORY TRACT CONGESTION 98 0.0576
88 RIGHT VENTRICULAR DILATATION 33 0.0570
89 CATHETER SITE RELATED REACTION 42 0.0560
90 HEART VALVE REPLACEMENT 82 0.0554
91 RIGHT VENTRICULAR DYSFUNCTION 61 0.0553
92 EXERCISE TOLERANCE DECREASED 299 0.0519
93 DERMATITIS CONTACT 587 0.0514
94 INTRA-ABDOMINAL FLUID COLLECTION 92 0.0513
95 CATHETER SITE INFECTION 190 0.0502
96 TRACHEOSTOMY 70 0.0490
97 OXYGEN SATURATION DECREASED 2742 0.0487
98 LUNG OPERATION 40 0.0477
99 UPPER RESPIRATORY TRACT CONGESTION 138 0.0476
100 DEVICE DAMAGE 37 0.0464
101 DEVICE RELATED SEPSIS 90 0.0447
102 SYSTEMIC SCLERODERMA 32 0.0440
103 OXYGEN THERAPY 72 0.0438
104 METAPNEUMOVIRUS INFECTION 34 0.0434
105 ASPIRATION PLEURAL CAVITY 33 0.0429
106 DIALYSIS 609 0.0429
107 TRANSFUSION 448 0.0427
108 BRAIN NATRIURETIC PEPTIDE INCREASED 131 0.0424
109 UNEVALUABLE EVENT 3164 0.0418
110 LIVER TRANSPLANT 150 0.0412
111 DEVICE CONNECTION ISSUE 87 0.0412
112 MIDDLE EAR EFFUSION 88 0.0399
113 INJECTION SITE INFECTION 131 0.0398
114 ARTERIOVENOUS MALFORMATION 36 0.0396
115 ENDOTRACHEAL INTUBATION 110 0.0392
116 LOCALISED OEDEMA 181 0.0391
117 CARDIAC PACEMAKER INSERTION 225 0.0377
118 SEASONAL ALLERGY 528 0.0373
119 CARDIAC ABLATION 64 0.0358
120 EAR CONGESTION 97 0.0358
121 HAEMOGLOBIN INCREASED 160 0.0350
122 OEDEMA PERIPHERAL 4223 0.0346
123 CARDIOVERSION 48 0.0343
124 SINUS CONGESTION 464 0.0343
125 DYSPNOEA 19248 0.0340
126 RESPIRATION ABNORMAL 231 0.0335
127 RESPIRATORY TRACT IRRITATION 34 0.0326
128 ADMINISTRATION SITE PAIN 37 0.0321
129 ACUTE RESPIRATORY FAILURE 612 0.0318
130 THROMBOSIS IN DEVICE 103 0.0314
131 LEFT VENTRICULAR FAILURE 108 0.0313
132 SYNCOPE 3120 0.0312
133 ECHOCARDIOGRAM ABNORMAL 43 0.0307
134 TRANSPLANT 73 0.0307
135 INJECTION SITE DISCHARGE 164 0.0305
136 INFUSION SITE MASS 33 0.0304
137 COLONOSCOPY 65 0.0295
138 HYPOXIA 1029 0.0292
139 DIZZINESS POSTURAL 279 0.0287
140 CARDIAC OPERATION 244 0.0284
141 PARANASAL SINUS DISCOMFORT 107 0.0282
142 PERICARDIAL EFFUSION 643 0.0278
143 CARDIAC FAILURE CONGESTIVE 2215 0.0275
144 CONNECTIVE TISSUE DISORDER 39 0.0274
145 PURULENT DISCHARGE 115 0.0269
146 FLUSHING 2710 0.0266
147 PERIPHERAL SWELLING 4080 0.0265
148 SINUS DISORDER 520 0.0262
149 PAINFUL RESPIRATION 63 0.0261
150 THERAPY CHANGE 256 0.0260
151 RHINOVIRUS INFECTION 101 0.0259
152 PRESYNCOPE 624 0.0256
153 AORTIC VALVE REPLACEMENT 32 0.0255
154 PARANASAL SINUS HYPERSECRETION 96 0.0251
155 THERAPEUTIC PROCEDURE 35 0.0250
156 PULMONARY PAIN 73 0.0250
157 ENTERITIS INFECTIOUS 42 0.0247
158 HAEMOPTYSIS 687 0.0246
159 ORTHOPNOEA 78 0.0245
160 TERMINAL STATE 163 0.0243
161 SWELLING 2274 0.0243
162 INFUSION SITE BRUISING 52 0.0241
163 DRUG TITRATION ERROR 62 0.0240
164 ATRIAL FLUTTER 190 0.0238
165 ANGIOPLASTY 35 0.0234
166 NASAL DRYNESS 147 0.0234
167 DYSENTERY 42 0.0225
168 PNEUMONIA 7286 0.0225
169 NASAL DISCHARGE DISCOLOURATION 31 0.0225
170 INTENTIONAL DOSE OMISSION 639 0.0224
171 VASODILATATION 56 0.0222
172 COMPLICATION ASSOCIATED WITH DEVICE 318 0.0219
173 BLOOD POTASSIUM ABNORMAL 58 0.0217
174 INTERNAL HAEMORRHAGE 243 0.0212
175 SARCOIDOSIS 101 0.0212
176 CHEST PAIN 3877 0.0209
177 DEVICE POWER SOURCE ISSUE 61 0.0209
178 BLOOD IRON DECREASED 246 0.0207
179 EPISTAXIS 1544 0.0206
180 CARDIAC FAILURE 1611 0.0200
181 CHEMOTHERAPY 75 0.0198
182 RESPIRATORY FAILURE 1443 0.0198
183 BLOOD PRESSURE SYSTOLIC DECREASED 89 0.0195
184 PNEUMONIA VIRAL 62 0.0194
185 DEVICE OCCLUSION 273 0.0194
186 CARDIAC DISCOMFORT 39 0.0193
187 BLADDER NEOPLASM 33 0.0193
188 RALES 112 0.0193
189 PULMONARY THROMBOSIS 209 0.0191
190 LUNG DISORDER 939 0.0191
191 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 992 0.0190
192 STENT PLACEMENT 153 0.0190
193 NO THERAPEUTIC RESPONSE 231 0.0189
194 HYPOTENSION 3776 0.0188
195 RESPIRATORY TRACT CONGESTION 297 0.0187
196 LUNG INFECTION 286 0.0184
197 PALPITATIONS 2132 0.0182
198 PRODUCT ADMINISTRATION INTERRUPTED 142 0.0181
199 PULMONARY OEDEMA 810 0.0181
200 GASTROENTERITIS VIRAL 326 0.0180
201 WEIGHT FLUCTUATION 186 0.0178
202 GOUT 312 0.0174
203 NON-CARDIAC CHEST PAIN 55 0.0174
204 HEADACHE 10875 0.0173
205 ASCITES 509 0.0173
206 NASAL OEDEMA 31 0.0171
207 EAR DISCOMFORT 175 0.0170
208 MITRAL VALVE DISEASE 30 0.0169
209 PRODUCTIVE COUGH 806 0.0169
210 HYSTERECTOMY 146 0.0168
211 AMMONIA INCREASED 86 0.0168
212 GENERALISED OEDEMA 208 0.0168
213 RESPIRATORY TRACT INFECTION VIRAL 39 0.0167
214 THYROIDECTOMY 29 0.0167
215 COUGH 4658 0.0166
216 EYE CONTUSION 35 0.0165
217 PULMONARY FIBROSIS 316 0.0165
218 RESPIRATORY SYNCYTIAL VIRUS INFECTION 142 0.0163
219 CARDIAC FAILURE ACUTE 108 0.0162
220 HEART RATE ABNORMAL 89 0.0159
221 FAECES SOFT 116 0.0159
222 DISEASE COMPLICATION 73 0.0159
223 BLOOD POTASSIUM DECREASED 478 0.0159
224 BRONCHITIS 1170 0.0158
225 AORTIC STENOSIS 55 0.0158
226 CARDIAC FLUTTER 102 0.0158
227 HAEMORRHOIDAL HAEMORRHAGE 77 0.0158
228 WRONG DOSE 38 0.0157
229 GASTRIC INFECTION 60 0.0157
230 LARGE INTESTINAL HAEMORRHAGE 35 0.0156
231 CLOSTRIDIUM DIFFICILE INFECTION 338 0.0155
232 SMALL INTESTINAL HAEMORRHAGE 31 0.0154
233 CHEST DISCOMFORT 1576 0.0154
234 IRON DEFICIENCY ANAEMIA 142 0.0154
235 MEDICAL DEVICE COMPLICATION 113 0.0153
236 THROAT IRRITATION 685 0.0153
237 IDIOPATHIC PULMONARY FIBROSIS 60 0.0152
238 LOCALISED INFECTION 363 0.0150
239 RENAL TRANSPLANT 54 0.0149
240 EMERGENCY CARE 45 0.0148
241 SINUS HEADACHE 88 0.0148
242 GASTRIC BYPASS 32 0.0147
243 CARDIAC VALVE DISEASE 84 0.0147
244 CELLULITIS 734 0.0146
245 INFUSION SITE EXTRAVASATION 90 0.0144
246 BREATH SOUNDS ABNORMAL 71 0.0144
247 NASOPHARYNGITIS 2652 0.0144
248 VIRAL UPPER RESPIRATORY TRACT INFECTION 68 0.0143
249 BLOOD PRESSURE DECREASED 949 0.0143
250 HYPERCAPNIA 43 0.0143
251 DEVICE DISLOCATION 620 0.0142
252 DRUG TOLERANCE DECREASED 40 0.0142
253 VIRAL INFECTION 468 0.0140
254 THERAPY NON-RESPONDER 623 0.0138
255 CARDIAC FAILURE CHRONIC 59 0.0138
256 PULMONARY HAEMORRHAGE 108 0.0138
257 SYSTEMIC LUPUS ERYTHEMATOSUS 484 0.0136
258 FOOD POISONING 73 0.0136
259 GASTROINTESTINAL TUBE INSERTION 34 0.0136
260 HEART VALVE INCOMPETENCE 39 0.0136
261 BRAIN OPERATION 31 0.0136
262 EYE OEDEMA 33 0.0134
263 ULCER HAEMORRHAGE 91 0.0134
264 GALLBLADDER OPERATION 54 0.0133
265 SINUS PAIN 31 0.0133
266 DIZZINESS 6625 0.0133
267 BLOOD PRESSURE ABNORMAL 264 0.0133
268 HYPOPNOEA 46 0.0132
269 DEATH 11390 0.0132
270 LIVER FUNCTION TEST ABNORMAL 383 0.0132
271 INFLUENZA 1467 0.0131
272 BLOOD COUNT ABNORMAL 199 0.0131
273 HEPATIC CIRRHOSIS 245 0.0130
274 CHOLECYSTITIS INFECTIVE 36 0.0130
275 DIASTOLIC DYSFUNCTION 40 0.0129
276 HEART RATE INCREASED 1270 0.0128
277 DECREASED ACTIVITY 138 0.0128
278 SECRETION DISCHARGE 160 0.0128
279 HEAD INJURY 403 0.0127
280 ATYPICAL PNEUMONIA 38 0.0127
281 CARDIAC DISORDER 1187 0.0127
282 HIP FRACTURE 406 0.0126
283 THERAPY INTERRUPTED 898 0.0126
284 LIMB OPERATION 60 0.0125
285 GASTRIC DISORDER 427 0.0124
286 CARDIOMEGALY 153 0.0124
287 PNEUMOTHORAX 197 0.0124
288 HEAD DISCOMFORT 217 0.0122
289 ATRIAL FIBRILLATION 1192 0.0122
290 MALAISE 5357 0.0122
291 PULMONARY CONGESTION 160 0.0121
292 PULSE ABNORMAL 29 0.0120
293 CYANOSIS 188 0.0119
294 PLEURAL EFFUSION 727 0.0119
295 UPPER-AIRWAY COUGH SYNDROME 98 0.0119
296 BACTERAEMIA 141 0.0119
297 IRON DEFICIENCY 53 0.0118
298 RESPIRATORY DISTRESS 323 0.0117
299 BLOOD CULTURE POSITIVE 35 0.0117
300 SINUSITIS 1194 0.0116
301 SPUTUM DISCOLOURED 110 0.0116
302 ABDOMINAL DISTENSION 1210 0.0116
303 NASAL DISCOMFORT 91 0.0115
304 ENDOCARDITIS 58 0.0113
305 STAPHYLOCOCCAL BACTERAEMIA 49 0.0113
306 EAR INFECTION 298 0.0112
307 HEART RATE IRREGULAR 252 0.0111
308 DIARRHOEA 7182 0.0111
309 RESPIRATORY TRACT INFECTION 289 0.0111
310 ANAEMIA 2107 0.0110
311 UPPER RESPIRATORY TRACT INFECTION 510 0.0110
312 HOSPICE CARE 109 0.0110
313 GASTRIC HAEMORRHAGE 125 0.0109
314 BEDRIDDEN 142 0.0108
315 MUSCULOSKELETAL CHEST PAIN 167 0.0108
316 SHOULDER ARTHROPLASTY 29 0.0108
317 PAIN IN EXTREMITY 3170 0.0107
318 EAR DISORDER 49 0.0107
319 SUPRAVENTRICULAR TACHYCARDIA 102 0.0106
320 EYE OPERATION 49 0.0106
321 RENAL DISORDER 495 0.0106
322 INCORRECT DRUG ADMINISTRATION RATE 45 0.0106
323 HOSPITALISATION 1624 0.0106
324 FACIAL PAIN 94 0.0105
325 GALLBLADDER DISORDER 185 0.0104
326 RETCHING 220 0.0103
327 LOSS OF CONSCIOUSNESS 1319 0.0103
328 PULMONARY FUNCTION TEST DECREASED 45 0.0103
329 APPARENT DEATH 37 0.0103
330 KIDNEY INFECTION 201 0.0102
331 LACERATION 96 0.0102
332 RESPIRATORY SYMPTOM 29 0.0102
333 CREPITATIONS 30 0.0101
334 SLEEP APNOEA SYNDROME 192 0.0101
335 DEVICE FAILURE 153 0.0100
336 WEIGHT INCREASED 2244 0.0100
337 HEARING IMPAIRED 60 0.0100
338 DEAFNESS UNILATERAL 55 0.0100
339 RESPIRATORY DISORDER 296 0.0099
340 GASTROINTESTINAL HAEMORRHAGE 826 0.0099
341 URINE OUTPUT DECREASED 86 0.0098
342 STAPHYLOCOCCAL INFECTION 324 0.0098
343 PULSELESS ELECTRICAL ACTIVITY 41 0.0098
344 THERAPY CESSATION 503 0.0098
345 LIGAMENT SPRAIN 96 0.0097
346 SENSITIVITY TO WEATHER CHANGE 51 0.0097
347 CHOKING SENSATION 53 0.0096
348 PHARYNGITIS STREPTOCOCCAL 104 0.0096
349 UPPER LIMB FRACTURE 191 0.0096
350 SICKLE CELL ANAEMIA WITH CRISIS 151 0.0096
351 OROPHARYNGEAL PAIN 880 0.0095
352 FACE INJURY 36 0.0095
353 LEG AMPUTATION 39 0.0095
354 SLUGGISHNESS 96 0.0094
355 PELVIC FRACTURE 73 0.0094
356 DRY THROAT 95 0.0093
357 CARDIOGENIC SHOCK 134 0.0093
358 POLYURIA 76 0.0093
359 APPENDICECTOMY 33 0.0092
360 HAEMOGLOBIN DECREASED 949 0.0092
361 RIB FRACTURE 188 0.0091
362 CLAVICLE FRACTURE 35 0.0091
363 RHINORRHOEA 589 0.0091
364 PRODUCT LEAKAGE 51 0.0091
365 REHABILITATION THERAPY 35 0.0090
366 SWELLING FACE 586 0.0090
367 ABDOMINAL DISCOMFORT 1505 0.0090
368 MIGRAINE 855 0.0089
369 LOCAL SWELLING 156 0.0089
370 ORGAN FAILURE 36 0.0089
371 MYALGIA 1517 0.0089
372 DEAFNESS 233 0.0089
373 HIP SURGERY 48 0.0089
374 DYSPEPSIA 869 0.0088
375 SEPSIS 982 0.0088
376 DEVICE LEAKAGE 381 0.0088
377 INTERNATIONAL NORMALISED RATIO ABNORMAL 30 0.0087
378 SKIN ABRASION 41 0.0087
379 SHOULDER OPERATION 37 0.0086
380 FATIGUE 6670 0.0086
381 WHEELCHAIR USER 38 0.0085
382 BLOOD PRESSURE DIASTOLIC DECREASED 63 0.0085
383 FALL 2836 0.0085
384 FEELING COLD 236 0.0085
385 WEIGHT DECREASED 2355 0.0084
386 DEHYDRATION 1123 0.0084
387 INCREASED UPPER AIRWAY SECRETION 43 0.0084
388 NAUSEA 6611 0.0083
389 FACIAL BONES FRACTURE 30 0.0083
390 HERNIA 161 0.0083
391 BACTERIAL INFECTION 155 0.0083
392 MULTIPLE ALLERGIES 65 0.0083
393 TOOTHACHE 150 0.0083
394 KNEE OPERATION 81 0.0082
395 CHOLECYSTECTOMY 94 0.0082
396 POOR PERIPHERAL CIRCULATION 35 0.0082
397 MOUTH HAEMORRHAGE 60 0.0082
398 HIP ARTHROPLASTY 125 0.0082
399 TREATMENT NONCOMPLIANCE 446 0.0081
400 SURGERY 476 0.0081
401 AUTOIMMUNE DISORDER 79 0.0081
402 MUSCLE STRAIN 70 0.0081
403 HAEMOGLOBIN ABNORMAL 52 0.0081
404 FOOT OPERATION 40 0.0081
405 WHEEZING 479 0.0081
406 VOMITING 3789 0.0081
407 HEPATIC ENCEPHALOPATHY 75 0.0080
408 FEELING OF BODY TEMPERATURE CHANGE 47 0.0080
409 LOWER LIMB FRACTURE 154 0.0080
410 JOINT SWELLING 963 0.0080
411 TOOTH INFECTION 105 0.0080
412 CARDIOPULMONARY FAILURE 31 0.0079
413 HAEMORRHAGE 828 0.0079
414 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 48 0.0079
415 THROMBOSIS 633 0.0079
416 GASTROOESOPHAGEAL REFLUX DISEASE 633 0.0079
417 LIVER DISORDER 348 0.0078
418 DIVERTICULITIS 216 0.0078
419 CARDIAC DYSFUNCTION 29 0.0078
420 OESOPHAGEAL DISORDER 30 0.0078
421 POLYP 51 0.0078
422 DECREASED APPETITE 1806 0.0078
423 LIMB INJURY 211 0.0078
424 ABDOMINAL PAIN UPPER 1593 0.0077
425 PNEUMONIA BACTERIAL 71 0.0077
426 EAR PAIN 150 0.0077
427 HOT FLUSH 580 0.0077
428 HAEMATEMESIS 194 0.0076
429 COMPRESSION FRACTURE 41 0.0076
430 EMPHYSEMA 77 0.0076
431 BACK INJURY 83 0.0076
432 ANKLE FRACTURE 118 0.0076
433 MUSCULOSKELETAL PAIN 399 0.0076
434 FAECES DISCOLOURED 165 0.0076
435 FEELING ABNORMAL 1823 0.0076
436 PULMONARY MASS 113 0.0076
437 BLOOD POTASSIUM INCREASED 123 0.0076
438 DEVICE PHYSICAL PROPERTY ISSUE 58 0.0076
439 SMALL INTESTINAL OBSTRUCTION 93 0.0075
440 ASTHENIA 2822 0.0075
441 TOE AMPUTATION 38 0.0075
442 PRODUCT DOSE OMISSION 488 0.0075
443 EYE SWELLING 276 0.0074
444 INTERNATIONAL NORMALISED RATIO DECREASED 30 0.0074
445 SKIN INFECTION 83 0.0074
446 RENAL FAILURE 980 0.0074
447 FLANK PAIN 69 0.0074
448 GASTROINTESTINAL DISORDER 658 0.0073
449 NECK PAIN 405 0.0072
450 INTRACRANIAL ANEURYSM 29 0.0072
451 FACE OEDEMA 121 0.0072
452 TOOTH ABSCESS 73 0.0072
453 OCULAR ICTERUS 31 0.0071
454 BLOOD DISORDER 57 0.0071
455 DRUG DOSE OMISSION 1176 0.0071
456 CORONARY ARTERIAL STENT INSERTION 36 0.0071
457 LYMPHOEDEMA 49 0.0071
458 KNEE ARTHROPLASTY 149 0.0071
459 RECTAL HAEMORRHAGE 302 0.0070
460 PRODUCT USE ISSUE 1318 0.0070
461 INFECTION 1015 0.0070
462 VEIN DISORDER 35 0.0070
463 TRISMUS 36 0.0070
464 CARDIAC ARREST 574 0.0069
465 FAILURE TO THRIVE 36 0.0069
466 RESTLESS LEGS SYNDROME 126 0.0069
467 GASTROINTESTINAL MOTILITY DISORDER 37 0.0069
468 HYPERSOMNIA 198 0.0069
469 RENAL FAILURE CHRONIC 53 0.0069
470 GASTROENTERITIS 100 0.0068
471 MENTAL STATUS CHANGES 190 0.0068
472 EYE INFECTION 77 0.0068
473 GINGIVAL BLEEDING 93 0.0068
474 TRICUSPID VALVE INCOMPETENCE 54 0.0068
475 HYPOACUSIS 292 0.0068
476 VARICOSE VEIN 35 0.0068
477 TENSION HEADACHE 29 0.0067
478 SARS-COV-2 TEST POSITIVE 89 0.0067
479 BACK PAIN 1558 0.0067
480 SNEEZING 149 0.0066
481 BACK DISORDER 108 0.0066
482 ELECTROLYTE IMBALANCE 77 0.0066
483 CATARACT 394 0.0066
484 ARTHROPOD BITE 49 0.0066
485 ABNORMAL LOSS OF WEIGHT 45 0.0066
486 WRIST FRACTURE 79 0.0066
487 SPINAL OPERATION 81 0.0066
488 RED BLOOD CELL COUNT DECREASED 186 0.0065
489 LARGE INTESTINE POLYP 45 0.0065
490 LIMB DISCOMFORT 201 0.0065
491 BLOOD MAGNESIUM DECREASED 56 0.0065
492 URINARY TRACT INFECTION 1103 0.0065
493 EYE HAEMORRHAGE 86 0.0064
494 COLON CANCER 95 0.0064
495 JOINT INJURY 136 0.0064
496 BLOOD SODIUM DECREASED 120 0.0064
497 SCIATICA 101 0.0063
498 FEEDING DISORDER 128 0.0063
499 INTESTINAL OBSTRUCTION 237 0.0063
500 ABORTION INDUCED 59 0.0063
501 CYSTITIS 199 0.0062
502 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
503 SPINAL FRACTURE 125 0.0062
504 FOOT FRACTURE 117 0.0062
505 FEELING HOT 378 0.0062
506 MIDDLE INSOMNIA 115 0.0062
507 HYPOVOLAEMIA 36 0.0061
508 POST PROCEDURAL COMPLICATION 118 0.0061
509 LUNG NEOPLASM MALIGNANT 252 0.0061
510 PROCEDURAL COMPLICATION 47 0.0061
511 PHARYNGITIS 76 0.0061
512 OROPHARYNGEAL DISCOMFORT 55 0.0061
513 SUBDURAL HAEMATOMA 87 0.0061
514 CONCUSSION 47 0.0061
515 SEPTIC SHOCK 264 0.0061
516 PLEURISY 36 0.0061
517 ROAD TRAFFIC ACCIDENT 253 0.0060
518 HAEMATOCHEZIA 332 0.0060
519 LETHARGY 345 0.0060
520 POOR QUALITY SLEEP 129 0.0060
521 RESPIRATORY RATE INCREASED 53 0.0060
522 NERVE COMPRESSION 55 0.0060
523 BREAST MASS 40 0.0060
524 HEART RATE DECREASED 209 0.0059
525 APHONIA 83 0.0059
526 THYROID DISORDER 91 0.0059
527 HAEMATOCRIT DECREASED 117 0.0059
528 ANGINA PECTORIS 169 0.0059
529 APPENDICITIS 55 0.0059
530 TOOTH EXTRACTION 73 0.0059
531 INTERNATIONAL NORMALISED RATIO INCREASED 167 0.0059
532 CLOSTRIDIUM DIFFICILE COLITIS 62 0.0058
533 COVID-19 PNEUMONIA 69 0.0058
534 ASPIRATION 64 0.0058
535 JAW DISORDER 32 0.0058
536 CONCOMITANT DISEASE AGGRAVATED 36 0.0058
537 DYSPHONIA 340 0.0058
538 DRUG INTOLERANCE 561 0.0058
539 DRY MOUTH 471 0.0058
540 ANAL INCONTINENCE 52 0.0058
541 HAEMODYNAMIC INSTABILITY 44 0.0058
542 ATRIAL SEPTAL DEFECT 48 0.0057
543 FLATULENCE 325 0.0057
544 HEPATOMEGALY 56 0.0057
545 CANDIDA INFECTION 96 0.0057
546 GASTRIC ULCER 108 0.0057
547 PERIORBITAL SWELLING 32 0.0057
548 ILLNESS 582 0.0056
549 APPETITE DISORDER 37 0.0056
550 INTERSTITIAL LUNG DISEASE 270 0.0056
551 FREQUENT BOWEL MOVEMENTS 150 0.0055
552 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
553 TINNITUS 254 0.0055
554 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
555 ACUTE PULMONARY OEDEMA 31 0.0055
556 CHOLELITHIASIS 180 0.0055
557 BOWEL MOVEMENT IRREGULARITY 42 0.0055
558 CHILLS 642 0.0055
559 ARTERIAL OCCLUSIVE DISEASE 43 0.0055
560 NEOPLASM MALIGNANT 364 0.0054
561 HAEMORRHOIDS 106 0.0054
562 INSURANCE ISSUE 83 0.0054
563 ERUCTATION 105 0.0054
564 CONSTIPATION 1181 0.0054
565 DEMENTIA 151 0.0054
566 CHOLECYSTITIS 64 0.0054
567 HYPERVENTILATION 31 0.0053
568 MUSCULOSKELETAL DISCOMFORT 92 0.0053
569 ULCER 85 0.0053
570 INJECTION SITE IRRITATION 68 0.0053
571 PERIPHERAL COLDNESS 73 0.0053
572 FOOD ALLERGY 41 0.0053
573 INFLUENZA LIKE ILLNESS 437 0.0053
574 NONSPECIFIC REACTION 29 0.0053
575 PYREXIA 1821 0.0053
576 CONDITION AGGRAVATED 1598 0.0053
577 PAIN 3213 0.0052
578 MELAENA 115 0.0052
579 STREPTOCOCCAL INFECTION 29 0.0052
580 CONTUSION 498 0.0052
581 SKIN LACERATION 56 0.0051
582 PALLOR 140 0.0051
583 DISEASE PROGRESSION 606 0.0051
584 GLAUCOMA 98 0.0051
585 FRUSTRATION TOLERANCE DECREASED 41 0.0051
586 MITRAL VALVE INCOMPETENCE 57 0.0050
587 ABDOMINAL PAIN 1169 0.0050
588 GASTROINTESTINAL INFECTION 45 0.0050
589 ABSCESS 80 0.0050
590 MUSCLE SPASMS 920 0.0050
591 SUDDEN DEATH 53 0.0050
592 INSOMNIA 1333 0.0050
593 ARTHRITIS 391 0.0050
594 PRODUCT DISTRIBUTION ISSUE 46 0.0050
595 SPINAL COMPRESSION FRACTURE 41 0.0050
596 HAEMATOMA 128 0.0049
597 UTERINE LEIOMYOMA 36 0.0049
598 TACHYCARDIA 437 0.0049
599 ILL-DEFINED DISORDER 298 0.0049
600 PRODUCT SUPPLY ISSUE 35 0.0049
601 SKIN ULCER 126 0.0049
602 THERAPY PARTIAL RESPONDER 76 0.0049
603 CHOKING 95 0.0049
604 HEPATIC FAILURE 146 0.0048
605 CORONAVIRUS INFECTION 32 0.0048
606 FEELING JITTERY 92 0.0048
607 MUSCLE TIGHTNESS 78 0.0048
608 DIARRHOEA HAEMORRHAGIC 45 0.0048
609 DEVICE BREAKAGE 195 0.0048
610 EATING DISORDER 102 0.0048
611 GAIT INABILITY 160 0.0048
612 DEVICE ISSUE 429 0.0048
613 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
614 ADVERSE EVENT 437 0.0047
615 ESCHERICHIA INFECTION 39 0.0047
616 TROPONIN INCREASED 36 0.0047
617 GENERAL PHYSICAL HEALTH DETERIORATION 547 0.0047
618 NEPHROPATHY 44 0.0047
619 ACCIDENT 56 0.0047
620 POST PROCEDURAL INFECTION 38 0.0047
621 LIVER FUNCTION TEST INCREASED 100 0.0047
622 NEURALGIA 113 0.0046
623 POST PROCEDURAL HAEMORRHAGE 54 0.0046
624 INCOHERENT 30 0.0046
625 MENORRHAGIA 91 0.0046
626 COVID-19 811 0.0046
627 PNEUMONIA ASPIRATION 115 0.0046
628 RHINITIS 37 0.0046
629 SKIN DISCOLOURATION 210 0.0046
630 NEPHROLITHIASIS 209 0.0046
631 VISUAL IMPAIRMENT 563 0.0045
632 ACCIDENTAL OVERDOSE 166 0.0045
633 UNRESPONSIVE TO STIMULI 117 0.0045
634 RENAL PAIN 48 0.0045
635 GINGIVAL PAIN 36 0.0045
636 MULTI-ORGAN FAILURE 78 0.0045
637 RASH PRURITIC 244 0.0045
638 BONE PAIN 263 0.0045
639 HYPOKALAEMIA 207 0.0045
640 HIATUS HERNIA 58 0.0045
641 ARRHYTHMIA 212 0.0045
642 HYPOPHAGIA 114 0.0045
643 OCULAR DISCOMFORT 50 0.0044
644 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
645 WOUND 124 0.0044
646 ARTHRALGIA 1825 0.0044
647 SCAB 50 0.0044
648 HAND FRACTURE 31 0.0044
649 VISION BLURRED 600 0.0044
650 JOINT DISLOCATION 46 0.0043
651 DISABILITY 86 0.0043
652 SENSITIVE SKIN 32 0.0043
653 ABASIA 107 0.0043
654 UNINTENTIONAL MEDICAL DEVICE REMOVAL 50 0.0043
655 EYE DISORDER 142 0.0043
656 GAIT DISTURBANCE 825 0.0043
657 MALNUTRITION 48 0.0043
658 ORAL CANDIDIASIS 56 0.0042
659 PRODUCT DOSE OMISSION IN ERROR 120 0.0042
660 VERTIGO 258 0.0042
661 BLADDER DISORDER 42 0.0042
662 CEREBRAL HAEMORRHAGE 151 0.0042
663 BLOOD URINE PRESENT 80 0.0042
664 HERPES ZOSTER 241 0.0042
665 HYPERSENSITIVITY 777 0.0042
666 LOWER RESPIRATORY TRACT INFECTION 190 0.0042
667 CARDIO-RESPIRATORY ARREST 174 0.0042
668 EXTRASYSTOLES 29 0.0041
669 GASTRITIS 109 0.0041
670 LEUKAEMIA 39 0.0041
671 TRANSIENT ISCHAEMIC ATTACK 139 0.0041
672 BODY TEMPERATURE INCREASED 84 0.0041
673 MACULAR DEGENERATION 49 0.0041
674 TOOTH DISORDER 91 0.0041
675 THERMAL BURN 29 0.0041
676 TEMPERATURE INTOLERANCE 42 0.0041
677 OCULAR HYPERAEMIA 193 0.0041
678 BLOOD PRESSURE FLUCTUATION 97 0.0040
679 LABORATORY TEST ABNORMAL 119 0.0040
680 THROAT TIGHTNESS 109 0.0040
681 INABILITY TO AFFORD MEDICATION 40 0.0040
682 INCREASED TENDENCY TO BRUISE 37 0.0040
683 CEREBROVASCULAR ACCIDENT 680 0.0040
684 FUNGAL INFECTION 133 0.0040
685 GROIN PAIN 35 0.0040
686 MUSCULAR WEAKNESS 452 0.0040
687 LACRIMATION INCREASED 120 0.0040
688 RENAL IMPAIRMENT 333 0.0040
689 PULMONARY EMBOLISM 376 0.0040
690 DEVICE MALFUNCTION 278 0.0040
691 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
692 RENAL FAILURE ACUTE 167 0.0039
693 CARDIAC MURMUR 34 0.0039
694 DECUBITUS ULCER 32 0.0039
695 BRONCHOSPASM 56 0.0039
696 NERVOUSNESS 205 0.0039
697 RESPIRATORY ARREST 108 0.0039
698 VITAMIN D DECREASED 33 0.0039
699 MEMORY IMPAIRMENT 528 0.0038
700 BLINDNESS UNILATERAL 54 0.0038
701 DEVICE USE ERROR 133 0.0038
702 MASS 53 0.0038
703 PANIC ATTACK 137 0.0038
704 BREAST PAIN 40 0.0037
705 POLLAKIURIA 156 0.0037
706 BLOOD GLUCOSE DECREASED 179 0.0037
707 DIABETES MELLITUS 284 0.0037
708 BALANCE DISORDER 321 0.0037
709 BLINDNESS 151 0.0037
710 PHARYNGEAL OEDEMA 57 0.0037
711 BLOOD TEST ABNORMAL 52 0.0037
712 DYSSTASIA 108 0.0037
713 COLITIS 140 0.0037
714 BRAIN INJURY 37 0.0037
715 INCONTINENCE 39 0.0037
716 MYOCARDIAL INFARCTION 643 0.0037
717 SPLENOMEGALY 43 0.0037
718 IMPAIRED GASTRIC EMPTYING 50 0.0037
719 ROTATOR CUFF SYNDROME 47 0.0037
720 ANXIETY 1036 0.0036
721 INTENTIONAL PRODUCT USE ISSUE 317 0.0036
722 OVARIAN CYST 36 0.0036
723 ERYTHEMA 738 0.0036
724 CHROMATURIA 81 0.0036
725 ASTHMA 405 0.0036
726 UROSEPSIS 33 0.0036
727 THIRST 63 0.0035
728 PLATELET COUNT DECREASED 374 0.0035
729 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
730 HELICOBACTER INFECTION 36 0.0035
731 BLISTER 196 0.0035
732 WOUND INFECTION 38 0.0035
733 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 166 0.0035
734 SKIN DISORDER 115 0.0034
735 TREMOR 572 0.0034
736 HEAVY MENSTRUAL BLEEDING 31 0.0034
737 SLEEP DISORDER 240 0.0034
738 HEPATITIS C 41 0.0034
739 ADVERSE REACTION 45 0.0034
740 HYPERTHYROIDISM 49 0.0034
741 ORTHOSTATIC HYPOTENSION 58 0.0033
742 PRURITUS GENERALISED 72 0.0033
743 VAGINAL HAEMORRHAGE 144 0.0033
744 DYSURIA 122 0.0033
745 HYPERHIDROSIS 425 0.0033
746 INTESTINAL PERFORATION 37 0.0033
747 NIGHT SWEATS 106 0.0033
748 ACTIVITIES OF DAILY LIVING IMPAIRED 65 0.0033
749 VENTRICULAR TACHYCARDIA 54 0.0033
750 HYPOAESTHESIA 489 0.0033
751 EYE PAIN 183 0.0032
752 HYPERTENSION 684 0.0032
753 LYMPHADENOPATHY 114 0.0032
754 ORAL PAIN 72 0.0032
755 ATELECTASIS 31 0.0032
756 TRANSAMINASES INCREASED 71 0.0032
757 PHOTOPHOBIA 60 0.0032
758 EXTRA DOSE ADMINISTERED 129 0.0032
759 APPLICATION SITE PRURITUS 72 0.0032
760 CONFUSIONAL STATE 512 0.0032
761 PANCREATITIS 167 0.0032
762 SPINAL PAIN 37 0.0032
763 RETINAL DETACHMENT 29 0.0032
764 MULTIPLE ORGAN DYSFUNCTION SYNDROME 89 0.0031
765 SPEECH DISORDER 164 0.0031
766 IRRITABLE BOWEL SYNDROME 67 0.0031
767 COLD SWEAT 55 0.0031
768 OFF LABEL USE 2726 0.0031
769 SHOCK 71 0.0031
770 SEIZURE 356 0.0031
771 BURNING SENSATION 216 0.0031
772 SKIN IRRITATION 141 0.0031
773 DYSPHAGIA 292 0.0031
774 INTERVERTEBRAL DISC PROTRUSION 67 0.0031
775 COAGULOPATHY 51 0.0031
776 SOMNOLENCE 607 0.0030
777 DIPLOPIA 78 0.0030
778 FIBROMYALGIA 73 0.0030
779 GASTROINTESTINAL PAIN 33 0.0030
780 TENDERNESS 31 0.0030
781 OSTEOPOROSIS 122 0.0030
782 VITREOUS FLOATERS 29 0.0029
783 PREGNANCY 59 0.0029
784 RASH 1281 0.0029
785 BRAIN FOG 46 0.0029
786 HEPATIC ENZYME INCREASED 200 0.0029
787 PARAESTHESIA 461 0.0029
788 LYMPHOMA 45 0.0029
789 TASTE DISORDER 59 0.0029
790 DEVICE ADHESION ISSUE 44 0.0029
791 ARTHROPATHY 159 0.0029
792 BIPOLAR DISORDER 31 0.0028
793 BLOOD CREATININE INCREASED 186 0.0028
794 LIP SWELLING 94 0.0028
795 PRODUCT DOSE OMISSION ISSUE 830 0.0028
796 CYST 35 0.0028
797 OSTEOMYELITIS 51 0.0028
798 RASH MACULAR 98 0.0028
799 END STAGE RENAL DISEASE 51 0.0028
800 EYE DISCHARGE 29 0.0028
801 AMNESIA 181 0.0028
802 CARDIOMYOPATHY 41 0.0028
803 PRURITUS 1063 0.0028
804 MOBILITY DECREASED 198 0.0028
805 PRODUCT AVAILABILITY ISSUE 62 0.0027
806 CORONARY ARTERY DISEASE 82 0.0027
807 HEPATIC FUNCTION ABNORMAL 101 0.0027
808 BLOOD UREA INCREASED 45 0.0027
809 MENTAL IMPAIRMENT 65 0.0027
810 ADVERSE DRUG REACTION 240 0.0027
811 FISTULA 30 0.0027
812 BLOOD BILIRUBIN INCREASED 72 0.0027
813 OESOPHAGITIS 29 0.0027
814 FULL BLOOD COUNT DECREASED 53 0.0026
815 CORONARY ARTERY OCCLUSION 36 0.0026
816 DEPRESSED MOOD 138 0.0026
817 HAEMORRHAGE INTRACRANIAL 39 0.0026
818 DISCOMFORT 159 0.0026
819 MOVEMENT DISORDER 83 0.0026
820 FEMUR FRACTURE 80 0.0026
821 BLOOD PRESSURE INCREASED 390 0.0025
822 QUALITY OF LIFE DECREASED 34 0.0025
823 MOOD ALTERED 69 0.0025
824 SWOLLEN TONGUE 79 0.0025
825 NEOPLASM 29 0.0025
826 ACUTE KIDNEY INJURY 386 0.0025
827 INCREASED APPETITE 48 0.0025
828 BLOOD CALCIUM DECREASED 28 0.0025
829 DEVICE USE ISSUE 43 0.0025
830 ABDOMINAL PAIN LOWER 62 0.0024
831 ACUTE MYOCARDIAL INFARCTION 72 0.0024
832 RASH GENERALISED 63 0.0024
833 URINARY INCONTINENCE 72 0.0024
834 IMMUNE SYSTEM DISORDER 32 0.0024
835 CARPAL TUNNEL SYNDROME 34 0.0024
836 PNEUMONITIS 66 0.0024
837 DYSGEUSIA 177 0.0024
838 HEPATIC CANCER 57 0.0024
839 ENCEPHALOPATHY 58 0.0024
840 INJECTION SITE PRURITUS 158 0.0024
841 PARAESTHESIA ORAL 34 0.0024
842 EYE PRURITUS 79 0.0023
843 INJECTION SITE ERYTHEMA 291 0.0023
844 MENTAL DISORDER 102 0.0023
845 APPLICATION SITE IRRITATION 29 0.0023
846 BLOOD GLUCOSE ABNORMAL 43 0.0023
847 HYPOAESTHESIA ORAL 35 0.0023
848 PROCEDURAL PAIN 64 0.0023
849 RESTLESSNESS 84 0.0023
850 AGEUSIA 57 0.0023
851 RASH ERYTHEMATOUS 109 0.0023
852 ASPARTATE AMINOTRANSFERASE INCREASED 119 0.0022
853 INJECTION SITE INDURATION 29 0.0022
854 DERMATITIS ALLERGIC 28 0.0022
855 DISORIENTATION 88 0.0022
856 NEUROPATHY PERIPHERAL 211 0.0022
857 PERICARDITIS 37 0.0022
858 EMOTIONAL DISORDER 67 0.0022
859 DEPRESSION 494 0.0022
860 COMA 102 0.0021
861 SKIN REACTION 30 0.0021
862 INJECTION SITE RASH 65 0.0021
863 FRACTURE 40 0.0021
864 SCAR 36 0.0021
865 SKIN CANCER 45 0.0021
866 ORAL DISCOMFORT 29 0.0021
867 INFLAMMATION 107 0.0021
868 TENDONITIS 32 0.0021
869 CIRCULATORY COLLAPSE 35 0.0021
870 CRYING 74 0.0020
871 SKIN HAEMORRHAGE 30 0.0020
872 IMPAIRED QUALITY OF LIFE 29 0.0020
873 WHITE BLOOD CELL COUNT INCREASED 76 0.0020
874 PRODUCT USE COMPLAINT 31 0.0020
875 HYPERKALAEMIA 69 0.0020
876 RASH PAPULAR 44 0.0020
877 THINKING ABNORMAL 36 0.0019
878 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
879 MUSCULOSKELETAL DISORDER 36 0.0019
880 IMPAIRED HEALING 62 0.0019
881 BREAST CANCER 174 0.0019
882 BRADYCARDIA 98 0.0018
883 DYSARTHRIA 69 0.0018
884 APPLICATION SITE ERYTHEMA 48 0.0018
885 PHOTOSENSITIVITY REACTION 30 0.0018
886 URTICARIA 304 0.0018
887 IRRITABILITY 109 0.0018
888 CARDIOVASCULAR DISORDER 46 0.0018
889 GLOSSODYNIA 40 0.0018
890 HEPATIC STEATOSIS 33 0.0018
891 JOINT STIFFNESS 46 0.0018
892 CONJUNCTIVITIS 32 0.0017
893 DRY EYE 86 0.0017
894 CHRONIC KIDNEY DISEASE 130 0.0017
895 MUSCULOSKELETAL STIFFNESS 149 0.0017
896 LIVER INJURY 41 0.0017
897 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
898 HYPONATRAEMIA 93 0.0016
899 PRODUCT ADMINISTRATION ERROR 33 0.0016
900 URINARY RETENTION 54 0.0016
901 DEEP VEIN THROMBOSIS 104 0.0016
902 APHASIA 48 0.0016
903 HAEMATURIA 54 0.0016
904 FEAR 42 0.0016
905 THROMBOCYTOPENIA 174 0.0016
906 RHEUMATOID ARTHRITIS 175 0.0015
907 ORAL HERPES 30 0.0015
908 UNDERDOSE 112 0.0015
909 INJECTION SITE SWELLING 117 0.0015
910 INJECTION SITE HAEMORRHAGE 121 0.0015
911 EXPOSURE DURING PREGNANCY 94 0.0015
912 HYPOGLYCAEMIA 72 0.0015
913 PRODUCT PRESCRIBING ISSUE 32 0.0015
914 CONVULSION 84 0.0015
915 INCORRECT DOSE ADMINISTERED 334 0.0015
916 OSTEOARTHRITIS 62 0.0015
917 DERMATITIS 30 0.0014
918 HEPATITIS 36 0.0014
919 ANGIOEDEMA 61 0.0014
920 HALLUCINATION 102 0.0014
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 272 0.0013
922 INJECTION SITE PAIN 407 0.0013
923 MOOD SWINGS 42 0.0013
924 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 237 0.0013
925 PANCYTOPENIA 73 0.0013
926 MATERNAL EXPOSURE DURING PREGNANCY 116 0.0013
927 DELIRIUM 45 0.0013
928 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
929 APPLICATION SITE PAIN 28 0.0013
930 PANCREATIC CARCINOMA 36 0.0012
931 DRUG INEFFECTIVE 1627 0.0012
932 VISUAL ACUITY REDUCED 41 0.0012
933 DISTURBANCE IN ATTENTION 66 0.0012
934 DRUG ADMINISTRATION ERROR 37 0.0012
935 COLITIS ULCERATIVE 53 0.0012
936 NERVOUS SYSTEM DISORDER 37 0.0012
937 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
938 COGNITIVE DISORDER 55 0.0012
939 STOMATITIS 70 0.0012
940 INJURY 81 0.0012
941 EYE IRRITATION 66 0.0011
942 PRODUCT SUBSTITUTION ISSUE 66 0.0011
943 DRY SKIN 153 0.0011
944 INCORRECT DOSE ADMINISTERED BY DEVICE 30 0.0011
945 SKIN LESION 31 0.0011
946 WHITE BLOOD CELL COUNT DECREASED 120 0.0011
947 EXPIRED PRODUCT ADMINISTERED 36 0.0011
948 DRUG INTERACTION 171 0.0011
949 THERAPEUTIC RESPONSE DECREASED 65 0.0011
950 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 76 0.0011
951 ALOPECIA 209 0.0011
952 BLOOD GLUCOSE INCREASED 195 0.0010
953 OVERDOSE 216 0.0010
954 ABNORMAL BEHAVIOUR 39 0.0010
955 NIGHTMARE 34 0.0010
956 SKIN EXFOLIATION 82 0.0010
957 AGITATION 69 0.0009
958 DYSKINESIA 38 0.0009
959 LEUKOPENIA 44 0.0009
960 PLASMA CELL MYELOMA 34 0.0009
961 DEVICE DIFFICULT TO USE 57 0.0009
962 ECZEMA 45 0.0009
963 SKIN BURNING SENSATION 61 0.0009
964 INTENTIONAL PRODUCT MISUSE 74 0.0008
965 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39 0.0008
966 ANGER 28 0.0008
967 HYPERGLYCAEMIA 29 0.0008
968 INJECTION SITE MASS 29 0.0008
969 INJECTION SITE REACTION 49 0.0007
970 MEDICATION ERROR 38 0.0007
971 BLADDER CANCER 40 0.0007
972 MULTIPLE SCLEROSIS 31 0.0006
973 THERAPEUTIC RESPONSE UNEXPECTED 29 0.0006
974 BLOOD CHOLESTEROL INCREASED 29 0.0006
975 INJECTION SITE BRUISING 49 0.0006
976 SUICIDAL IDEATION 56 0.0006
977 AGGRESSION 29 0.0006
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
979 ANAPHYLACTIC REACTION 31 0.0006
980 ACNE 42 0.0006
981 PROSTATE CANCER 39 0.0005
982 PRODUCT USE IN UNAPPROVED INDICATION 116 0.0005
983 DRUG ABUSE 36 0.0004
984 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
985 NO ADVERSE EVENT 77 0.0004
986 TREATMENT FAILURE 29 0.0003
987 TOXICITY TO VARIOUS AGENTS 58 0.0003
988 NEUTROPENIA 43 0.0003
989 PSORIASIS 40 0.0003
990 PRODUCT QUALITY ISSUE 30 0.0002